CLGNCollPlant Biotechnologies Ltd

Nasdaq collplant.com


$ 5.99 $ -0.12 (-1.81 %)    

Wednesday, 08-May-2024 15:29:37 EDT
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 6.628
$ 5.99
$ 5.79 x 100
$ 0.00 x 0
$ 5.99 - $ 5.99
$ 4.22 - $ 8.90
1,707
na
75.91M
$ 0.84
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-collplant-biotechnologies-maintains-11-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates CollPlant Biotechnologies (NASDAQ:CLGN) with a Buy and mai...

 collplant-biotechnologies-q4-adj-eps-035-misses-007-estimate-sales-29900k-miss-856m-estimate

CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly Adj losses of $(0.35) per share which missed the analyst consensus e...

 earnings-scheduled-for-april-4-2024

Companies Reporting Before The Bell • Conagra Brands (NYSE:CAG) is likely to report quarterly earnings at $0.65 per share on r...

 collplant-biotechnologies-issues-letter-to-shareholders

Dear Shareholders,As we look toward a promising and exciting year ahead, I am proud to reflect on CollPlant's main achievem...

 collplant-biotechnologies-begins-preclinical-trial-with-commercial-size-regenerative-breast-implants

CollPlant Biotechnologies (NASDAQ:CLGN), a regenerative and aesthetics medicine company developing innovative technologies and ...

 hc-wainwright--co-reiterates-buy-on-collplant-biotechnologies-maintains-11-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates CollPlant Biotechnologies (NASDAQ:CLGN) with a Buy and mai...

 earnings-scheduled-for-november-29-2023

Companies Reporting Before The Bell • CollPlant Biotechnologies (NASDAQ:CLGN) is likely to report quarterly loss at $0.13 per ...

 collplant-biotechnologies-q3-adj-eps-035-misses-013-estimate-sales-4300k-miss-350m-estimate

CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly adjusted losses of $(0.35) per share which missed the analyst consen...

 hc-wainwright--co-reiterates-buy-on-collplant-biotechnologies-maintains-11-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates CollPlant Biotechnologies (NASDAQ:CLGN) with a Buy and mai...

 collplant-biotechnologies-q2-adjusted-eps-052-beats-001-estimate-sales-1018m-beat-515m-estimate

CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly earnings of $0.52 per share which beat the analyst consensus estimat...

 earnings-scheduled-for-august-24-2023

Companies Reporting Before The Bell • 111 (NASDAQ:YI) is estimated to report earnings for its second quarter.

 why-carnival-shares-are-trading-lower-by-9-here-are-other-stocks-moving-in-mondays-mid-day-session

Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION